Results 71 to 80 of about 15,592 (224)

Emerging therapeutic options for sporadic inclusion body myositis

Therapeutics and Clinical Risk Management, 2015
Lindsay N Alfano, Linda P Lowes Nationwide Children’s Hospital, Center for Gene Therapy, Columbus, OH, USA Abstract: Sporadic inclusion body myositis is the most common inflammatory muscle disorder preferentially affecting males over the age of ...
Alfano LN, Lowes LP
doaj  

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan

Orphanet Journal of Rare Diseases, 2016
Background Sporadic inclusion body myositis (sIBM) is the most prevalent acquired muscle disease in the elderly. sIBM is an intractable and progressive disease of unknown cause and without effective treatment.
Naoki Suzuki, Madoka Mori-Yoshimura, Satoshi Yamashita, Satoshi Nakano, Ken-ya Murata, Yukie Inamori, Naoko Matsui, En Kimura, Hirofumi Kusaka, Tomoyoshi Kondo, Itsuro Higuchi, Ryuji Kaji, Maki Tateyama, Rumiko Izumi, Hiroya Ono, Masaaki Kato, Hitoshi Warita, Toshiaki Takahashi, Ichizo Nishino, Masashi Aoki   +19 more
doaj   +1 more source

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis. [PDF]

PLoS ONE, 2011
BACKGROUND: Inclusion body myositis (IBM) is a poorly understood and refractory autoimmune muscle disease. Though widely believed to have no significant humoral autoimmunity, we sought to identify novel autoantibodies with high specificity for this ...
Mohammad Salajegheh, Theresa Lam, Steven A Greenberg   +2 more
doaj   +1 more source

The EuroMyositis registry: an international collaborative tool to facilitate myositis research [PDF]

, 2017
Aims: The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory myopathy (IIM) research community. This inaugural report examines pooled Registry data.
Andersson, Helena, Benveniste, Olivier, Betteridge, Zoe E, Chinoy, Hector, Contributors, EuroMyositis, Cooper, Robert G, Danieli, Maria Giovanna, Danko, Katalin, De Paepe, Boel, debleecker, Jan L, Diederichsen, Louise Pyndt, Krogh, Niels Steen, Lamb, Janine A, Lilleker, James B, Lundberg, Ingrid E, Maurer, Britta, McCann, Liza J, McHugh, Neil, New, Paul, Oakley, Paula, Ollier, William E, Pipitone, Nicolo, Schmidt, Jens, Thuy, Nguyen Thi Phuong, Vazquez-Del Mercado, Monica, Vencovsky, Jiri, Wang, Guochun, Wedderburn, Lucy R   +27 more
core   +7 more sources

Role of noninvasive ventilation in perioperative patients with neuromuscular disease: a clinical case

Brazilian Journal of Anesthesiology, 2016
The inclusion body myositis is an inflammatory myopathy that leads to chronic muscle inflammation associated with muscle weakness. It is characterized by a restrictive ventilatory syndrome requiring ventilatory support under non-invasive ventilation. The
Ana Marinho, Mario José Guimarães, Neusa Cristina Ribeiro Lages, Carlos Correia   +3 more
doaj   +3 more sources

Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution? [PDF]

, 2018
Inclusion body myositis (IBM), the most common inflammatory myopathy in the elderly, is often resistant to various forms of therapy. Placebo-controlled treatment trials with high dose intravenous immunoglobulins (IVIG) have shown disease amelioration in ...
Arndt, Börge, Bremer, Juliane, Fontana, Adriano, Recher, Mike, Sahrbacher, Ulrike, Steiner, Urs   +5 more
core  

Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy : an intra- and interrater reliability and validity study [PDF]

, 2018
Manual muscle testing (MMT) and hand-held dynamometry (HHD) are commonly used in people with inflammatory myopathy (IM), but their clinimetric properties have not yet been sufficiently studied.
Baschung Pfister, Pierrette, de Bie, Rob A., de Bruin, Eling D., Knols, Ruud H., Maurer, Britta, Sterkele, Iris   +5 more
core   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Anesthetic management of a hydrocephalus patient with inclusion body myositis

JA Clinical Reports, 2017
Inclusion body myositis (IBM) is an inflammatory muscle disease characterized by slowly progressive muscle weakness and wasting, especially affecting proximal leg and distal arm.
Daiki Takekawa, Hirotaka Kinoshita, Tomoyuki Kudo, Masato Kitayama, Tetsuya Kushikata, Kazuyoshi Hirota   +5 more
doaj   +1 more source

Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England [PDF]

, 2015
Concerns have been raised over breed-related health issues in purebred dogs, but reliable prevalence estimates for disorders within specific breeds are sparse.
Brodbelt, D C, Church, D B, McGreevy, P D, O'Neill, D G, Summers, J F, Thomson, P C   +5 more
core   +3 more sources